Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Medtronic launches new diabetes tech integrated with Abbott sensor
Two of the world's leading healthcare companies have partnered on a new treatment option for patients with type 1 diabetes.
$V-Wave has gained considerable attention or its Ventura Interatrial Shunt System, a small implantable device designed to reduce pressure on the left atrium and the lungs in patients with heart failure with reduced ejection fraction (HFrEF). The Ventura device includes a nitinol hourglass-shaped frame that anchors to the patient’s fossa ovalis in a way that prevents migration or embolization. It is implanted via an interventional procedure with fluoroscopy and echocardiography guidance.$
FDA panel votes against approving first-of-its-kind heart failure device
All 15 members of the FDA's Circulatory System Devices Panel agreed that more data is required to confirm the new device from Johnson & Johnson MedTech is effective. Will the agency agree with these recommendations? Only time will tell.
FDA issues warning about Olympus ligating devices after 113 injuries
The nylon loop on some devices can fail to release while removing polyps. Because of the severe risk to patient health, the FDA has designated this recall a Class I.
Patient communication AI company receives $65M in funding from private equity
Artera, a company that utilizes AI for patient communications, made the announcement while revealing it has achieved $100 million in annual revenue. Its products use AI for follow-ups after patient care, in addition to supporting clinical decisions.
Interventional cardiology groups unite to push the specialty forward
SCAI and CRT have announced a new partnership focused on education, advocacy and research.

MiniMed 780G system integrated with Instinct sensors manufactured by Abbott.

Medtronic launches new diabetes tech integrated with Abbott sensor

Two of the world's leading healthcare companies have partnered on a new treatment option for patients with type 1 diabetes.

$V-Wave has gained considerable attention or its Ventura Interatrial Shunt System, a small implantable device designed to reduce pressure on the left atrium and the lungs in patients with heart failure with reduced ejection fraction (HFrEF). The Ventura device includes a nitinol hourglass-shaped frame that anchors to the patient’s fossa ovalis in a way that prevents migration or embolization. It is implanted via an interventional procedure with fluoroscopy and echocardiography guidance.$

FDA panel votes against approving first-of-its-kind heart failure device

All 15 members of the FDA's Circulatory System Devices Panel agreed that more data is required to confirm the new device from Johnson & Johnson MedTech is effective. Will the agency agree with these recommendations? Only time will tell.

FDA issues warning about Olympus ligating devices after 113 injuries

The nylon loop on some devices can fail to release while removing polyps. Because of the severe risk to patient health, the FDA has designated this recall a Class I.

Patient communication AI company receives $65M in funding from private equity

Artera, a company that utilizes AI for patient communications, made the announcement while revealing it has achieved $100 million in annual revenue. Its products use AI for follow-ups after patient care, in addition to supporting clinical decisions.

heart doctors and surgeons working together. top cardiology hospitals in the United States.

Interventional cardiology groups unite to push the specialty forward

SCAI and CRT have announced a new partnership focused on education, advocacy and research.

SavvyWire OpSens TAVR guidewire owned by Haemonetics

3-in-1 TAVR guidewire linked to faster procedures, less radiation

The sensor-guided device delivers continuous hemodynamic measurements and rapid left ventricular pacing during TAVR procedures. Back in 2023, it was at the heart of a $253 million acquisition.

Stem cell company acquires 2 cardiology practices, calling them ‘the first of many’

Hemostemix believes its new cell therapy platform can help treat peripheral artery disease, congestive heart failure, cardiomyopathy and other serious medical conditions. The company plans on scooping up multiple practices to conduct additional research and increase the use of its platform.

FDA recall medical device recall product recall

FDA announces Class I recall of patches used for heart surgery

There is a risk of certain pericardial patches not being as strong or durable as needed. Customers are urged to identify, quarantine and replace these devices.